Skip to content

Group exercise therapy for mobility and balance in people with multiple sclerosis

Group exercise therapy for mobility and balance in people with multiple sclerosis: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN78227711
Enrollment
160
Registered
2008-10-17
Start date
2008-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis with balance and mobility problems Nervous System Diseases Multiple sclerosis

Interventions

The exercise group will attend an exercise class twice per week for 6 weeks. The exercises will consist of 8 different stations and will be staged according to ability. Each class will last approximat

Sponsors

University of Ulster (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of MS 2. Male or female, over 18 years of age 3. In a stable phase of their MS 4. Cognitively they must have a Score of 6 or more in the 10-point mini mental score (Hodkinson, 1972) 5. A minimum score of 14 on the Rivermead Mobility Index

Exclusion criteria

Exclusion criteria: 1. The Expanded Disability Status Scale (EDSS) >7.00 2. Serious other medical or surgical condition

Design outcomes

Primary

MeasureTime frame
Rivermead Mobility Index, assessed at baseline, immediately after the 6 weeks of intervention, and 3 and 6 months following discharge from the intervention. Analysis will be conducted on an intention to treat basis.

Secondary

MeasureTime frame
The following will be assessed at baseline, immediately after the 6 weeks of intervention, and 3 and 6 months following discharge from the intervention: 1. Berg Balance Scale 2. The Multiple Sclerosis Impact Scale (MSIS-29) 3. Multiple Sclerosis Walking Scale-12 4. Barthel Index 5. MS Self-efficacy Scale Analysis will be conducted on an intention to treat basis.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026